NVRO Nevro Corp

  1. Stocks
  2. Healthcare
  3. NYSE: NVRO

Price (delayed)

$12.27

Market cap

$446.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.56

Enterprise value

$557.88M

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
The EPS has increased by 11% since the previous quarter
The net income has grown by 10% from the previous quarter
The equity has contracted by 9% YoY but it has grown by 2.6% from the previous quarter
NVRO's quick ratio is down by 16% year-on-year
The debt is up by 11% since the previous quarter and by 10% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://www.nevro.com
Peers: ISRG TMO OFIX TNDM

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
36.4M
Market cap
$446.6M
Enterprise value
$557.88M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
1.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.31
Earnings
Revenue
$425.17M
EBIT
-$89.85M
EBITDA
-$78.31M
Free cash flow
-$67.42M
Per share
EPS
-$2.56
Free cash flow per share
-$1.87
Book value per share
$8.1
Revenue per share
$11.82
TBVPS
$15.85
Balance sheet
Total assets
$635.71M
Total liabilities
$342.57M
Debt
$216.11M
Equity
$293.15M
Working capital
$447.55M
Liquidity
Debt to equity
0.74
Current ratio
6.37
Quick ratio
4.83
Net debt/EBITDA
-1.42
Margins
EBITDA margin
-18.4%
Gross margin
68.2%
Net margin
-21.7%
Operating margin
-23.4%
Efficiency
Return on assets
-15.8%
Return on equity
-31.4%
Return on invested capital
-14.6%
Return on capital employed
-16.3%
Return on sales
-21.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
1.66%
1 week
-1.76%
1 month
-9.51%
1 year
-63.06%
YTD
-42.98%
QTD
-15.03%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$425.17M
Gross profit
$290.06M
Operating income
-$99.31M
Net income
-$92.21M
Gross margin
68.2%
Net margin
-21.7%
The net income has grown by 10% from the previous quarter
The net margin is up by 10% since the previous quarter
The operating margin has grown by 8% from the previous quarter
NVRO's operating income is up by 7% QoQ

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
1.52
P/S
1.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.31
The EPS has increased by 11% since the previous quarter
NVRO's P/B is 84% below its 5-year quarterly average of 9.7 and 51% below its last 4 quarters average of 3.1
The equity has contracted by 9% YoY but it has grown by 2.6% from the previous quarter
The P/S is 86% lower than the 5-year quarterly average of 7.5 and 53% lower than the last 4 quarters average of 2.2
The revenue has grown by 4.6% YoY

Efficiency

How efficient is Nevro business performance
The ROA has grown by 11% from the previous quarter
NVRO's return on equity is up by 8% since the previous quarter
The return on sales has increased by 6% since the previous quarter
The company's return on invested capital rose by 5% QoQ

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 86% greater than its total liabilities
The total liabilities has grown by 24% from the previous quarter and by 23% YoY
NVRO's quick ratio is down by 16% year-on-year
The debt is 26% smaller than the equity
The debt to equity has increased by 21% YoY and by 9% QoQ
The debt is up by 11% since the previous quarter and by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.